342 related articles for article (PubMed ID: 38049682)
21. The strategies to cure cancer patients by eradicating cancer stem-like cells.
Mai Y; Su J; Yang C; Xia C; Fu L
Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein signaling is a possible therapeutic target in gynecologic cancer.
Fukuda T; Suzuki E; Fukuda R
Cancer Sci; 2023 Mar; 114(3):722-729. PubMed ID: 36468782
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Raja E; Morikawa M; Nishida J; Tanabe R; Takahashi K; Seeherman HJ; Saito N; Todo T; Miyazono K
Cancer Sci; 2019 Nov; 110(11):3486-3496. PubMed ID: 31483918
[TBL] [Abstract][Full Text] [Related]
24. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
25. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
Paul R; Dorsey JF; Fan Y
Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
[TBL] [Abstract][Full Text] [Related]
26. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of NF-κB Signaling Reduces the Stemness Characteristics of Lung Cancer Stem Cells.
Zakaria N; Mohd Yusoff N; Zakaria Z; Widera D; Yahaya BH
Front Oncol; 2018; 8():166. PubMed ID: 29868483
[TBL] [Abstract][Full Text] [Related]
28. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
29. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
30. Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.
Fang X; Yan Q; Liu S; Guan XY
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293184
[TBL] [Abstract][Full Text] [Related]
31. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
32. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
33. Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of β-catenin in colon cancer stem cells.
Panda PK; Naik PP; Praharaj PP; Meher BR; Gupta PK; Verma RS; Maiti TK; Shanmugam MK; Chinnathambi A; Alharbi SA; Sethi G; Agarwal R; Bhutia SK
Mol Carcinog; 2018 May; 57(5):664-677. PubMed ID: 29457276
[TBL] [Abstract][Full Text] [Related]
34. A synthetic BMP-2 mimicking peptide induces glioblastoma stem cell differentiation.
Rampazzo E; Dettin M; Maule F; Scabello A; Calvanese L; D'Auria G; Falcigno L; Porcù E; Zamuner A; Della Puppa A; Boso D; Basso G; Persano L
Biochim Biophys Acta Gen Subj; 2017 Sep; 1861(9):2282-2292. PubMed ID: 28687190
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
Kapoor-Narula U; Lenka N
Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
[TBL] [Abstract][Full Text] [Related]
36. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
Chanmee T; Ontong P; Kimata K; Itano N
Front Oncol; 2015; 5():180. PubMed ID: 26322272
[TBL] [Abstract][Full Text] [Related]
37. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
[TBL] [Abstract][Full Text] [Related]
38. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.
Langenfeld E; Deen M; Zachariah E; Langenfeld J
Mol Cancer; 2013 Oct; 12(1):129. PubMed ID: 24160469
[TBL] [Abstract][Full Text] [Related]
39. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
40. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.
Wu Y; Richard JP; Wang SD; Rath P; Laterra J; Xia S
Cancer Sci; 2012 Jun; 103(6):1028-37. PubMed ID: 22380883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]